Aetna Class Action Lawsuit Filed Over Thousands Of HIV Status Disclosures

The insurance company Aetna faces a class action lawsuit that alleges the HIV status of certain customers was revealed, when the company sent letters in “window” envelopes that allowed others to see information about certain medications used. 

The complaint (PDF) was filed in the U.S. District Court for the Eastern District of Pennsylvania on August 28, by a plaintiff using the pseudonym “Andrew Beckett”, which is the name of the main character from the movie “Philadelphia”, which is credited for raising awareness about the AIDS epidemic. The pseudonym is meant to conceal the plaintiff’s identify to prevent further information becoming public about his HIV status.

According to the lawsuit, Aetna has repeatedly failed to protect the privacy of individuals taking HIV medications. The lawsuit indicates that Aetna sent notifications to 12,000 customers through a third party vendor, which provided information about their medications in envelopes with clear plastic “windows” that allowed others to see the individual’s HIV status.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The notifications were the result of a previous settlement regarding the company’s practices toward HIV patients. Several years ago, two Aetna class action lawsuits were filed over its practice of requiring patients to receive their HIV medications through the mail, instead of allowing them to pick them up at a pharmacy.

Plaintiffs in those cases also alleged that Aetna was jeopardizing their privacy. Aetna settled with the individual plaintiffs for about $24,000 plus legal fees. The letters that allegedly revealed their HIV status were meant to notify patients that they no longer had to receive their medications through the mail.

“The instructions about how individuals could obtain their HIV medications were visible from the outside of the envelope,” the lawsuit notes. ” Defendants’ actions… carelessly, recklessly, negligently, and impermissibly revealed HIV-related information of their current and former insureds to their family, friends, roommates, landlords, neighbors, mail carriers and complete strangers.”

The lawsuit presents charges that Aetna violated the Pennsylvania Confidentiality of HIV-Related Information Act, as well as charges of neglect, breach of contract, invasion of privacy, violation of Pennsylvania consumer protection laws and unjust enrichment.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.